{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T12:34:28Z","timestamp":1769171668211,"version":"3.49.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":4445,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1046\/j.1365-2133.2003.05269.x","type":"journal-article","created":{"date-parts":[[2003,7,23]],"date-time":"2003-07-23T09:22:50Z","timestamp":1058952170000},"page":"138-145","source":"Crossref","is-referenced-by-count":81,"title":["An evaluation of the usefulness of mycophenolate mofetil in pemphigus"],"prefix":"10.1093","volume":"149","author":[{"given":"A.M.","family":"Powell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Al Fares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.E.","family":"Harman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Setterfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bhogal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"b1_542","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.76"},{"key":"b2_543","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2133.1988.tb07104.x","volume":"119","author":"Pasricha J","year":"1988","journal-title":"Br J Dermatol"},{"key":"b3_544","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.57"},{"key":"b4_545","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJM198205203062001","volume":"306","author":"Anhalt GJ","year":"1982","journal-title":"N Engl J Med"},{"key":"b5_546","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1172\/JCI115968","volume":"90","author":"Amagai M","year":"1992","journal-title":"J Clin Invest"},{"key":"b6_547","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.4049\/jimmunol.163.11.6228","volume":"163","author":"Fan JL","year":"1999","journal-title":"J Immunol"},{"key":"b7_548","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04030.x"},{"key":"b8_549","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0190-9622(00)90231-7","volume":"42","author":"Katz KH","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"b9_550","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03365.x"},{"key":"b10_551","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.03177.x"},{"key":"b11_552","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0190-9622(99)70084-8","volume":"40","author":"Grundmann-Kollmann M","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"b12_553","doi-asserted-by":"publisher","DOI":"10.1053\/jd.1999.v40.a95204"},{"key":"b13_554","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.1.54"},{"key":"b14_555","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04132.x"},{"key":"b15_556","unstructured":"15 National Cancer Institute .Common Toxicity Criteria Manual. National Cancer Institute, Cancer Therapy Evaluation Program, Version 2.0, June 1999 . http:\/\/ctep.cancer.gov\/forms\/CTCManual_v4_10-4-99.pdf."},{"key":"b16_557","volume-title":"Mycophenolate Mofetil Prescribing Information, Summary of Product Characteristics","author":"Hoffmann-La Roche Inc.","year":"1998"},{"key":"b17_558","doi-asserted-by":"publisher","DOI":"10.1016\/S0738-081X(00)00191-7"},{"key":"b18_559","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03660.x"},{"key":"b19_560","first-page":"77","volume":"12","author":"Anhalt GJ","year":"1997","journal-title":"Adv Dermatol"},{"key":"b20_561","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04608.x"},{"key":"b21_562","unstructured":"21 AM Powell, S Albert, and N Oyama et al.Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans . J Eur Acad Dermatol Venereol."},{"key":"b22_563","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.7.854"},{"key":"b23_564","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.7.853"},{"key":"b24_565","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0190-9622(87)70285-0","volume":"17","author":"Epinette WW","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"b25_566","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0190-9622(97)70147-6","volume":"37","author":"Kitchin JE","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"b26_567","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","volume":"345","author":"European Mycophenolate Mofetil Cooperative Study Group.","year":"1995","journal-title":"Lancet"},{"key":"b27_568","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","volume":"60","author":"Sollinger HW","year":"1995","journal-title":"Transplantation"},{"key":"b28_569","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","volume":"61","author":"The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.","year":"1996","journal-title":"Transplantation"},{"key":"b29_570","doi-asserted-by":"crossref","unstructured":"29 P Halloran, T Mathew, and S Tomlanovich et al.Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups. (Erratum published inTransplantation1997;63:618.) Transplantation1997 ;63:39 -47 .","DOI":"10.1097\/00007890-199701150-00008"},{"key":"b30_571","doi-asserted-by":"publisher","DOI":"10.1016\/S0162-3109(00)00188-0"},{"key":"b31_572","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1681\/ASN.V8101592","volume":"8","author":"Sullivan SD","year":"1997","journal-title":"J Am Soc Nephrol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2003.05269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2003.05269.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T09:54:14Z","timestamp":1704880454000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/149\/1\/138\/6635331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["10.1046\/j.1365-2133.2003.05269.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05269.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}